The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor.
Golgi apparatus
MET
PSI domain
oncogene
protein disulfide isomerase
protein maturation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
17 Oct 2022
17 Oct 2022
Historique:
received:
05
09
2022
revised:
28
09
2022
accepted:
13
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
The tyrosine kinase receptor encoded by the MET oncogene has been extensively studied. Surprisingly, one extracellular domain, PSI, evolutionary conserved between plexins, semaphorins, and integrins, has no established function. The MET PSI sequence contains two CXXC motifs, usually found in protein disulfide isomerases (PDI). Using a scrambled oxidized RNAse enzymatic activity assay in vitro, we show, for the first time, that the MET extracellular domain displays disulfide isomerase activity, abolished by PSI domain antibodies. PSI domain deletion or mutations of CXXC sites to AXXA or SXXS result in a significant impairment of the cleavage of the MET 175 kDa precursor protein, abolishing the maturation of α and β chains, of, respectively, 50 kDa and 145 kDa, disulfide-linked. The uncleaved precursor is stuck in the Golgi apparatus and, interestingly, is constitutively phosphorylated. However, no signal transduction is observed as measured by AKT and MAPK phosphorylation. Consequently, biological responses to the MET ligand-hepatocyte growth factor (HGF)-such as growth and epithelial to mesenchymal transition, are hampered. These data show that the MET PSI domain is functional and is required for the maturation, surface expression, and biological functions of the MET oncogenic protein.
Identifiants
pubmed: 36293286
pii: ijms232012427
doi: 10.3390/ijms232012427
pmc: PMC9604360
pii:
doi:
Substances chimiques
Hepatocyte Growth Factor
67256-21-7
Protein Disulfide-Isomerases
EC 5.3.4.1
Ligands
0
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Proto-Oncogene Proteins c-met
EC 2.7.10.1
Semaphorins
0
Disulfides
0
Integrins
0
Ribonucleases
EC 3.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian Association for Cancer Research
ID : 23820
Références
Cancer Metastasis Rev. 2008 Mar;27(1):85-94
pubmed: 18175071
Int J Mol Sci. 2017 Sep 13;18(9):
pubmed: 28902178
FEBS Lett. 1993 Aug 9;328(1-2):25-9
pubmed: 8344430
Nat Rev Mol Cell Biol. 2010 Dec;11(12):834-48
pubmed: 21102609
Expert Opin Ther Targets. 2009 May;13(5):569-81
pubmed: 19397476
Cell. 2013 Jan 31;152(3):543-56
pubmed: 23374349
Biochem J. 2004 Aug 1;381(Pt 3):e3-4
pubmed: 15270700
J Clin Invest. 2012 Jun;122(6):2104-13
pubmed: 22565308
Biochem J. 1991 Apr 15;275 ( Pt 2):349-53
pubmed: 2025222
Biosci Rep. 2020 Oct 30;40(10):
pubmed: 33095243
J Biol Chem. 1994 Oct 7;269(40):24550-2
pubmed: 7929125
J Biol Chem. 2008 Feb 15;283(7):4344-51
pubmed: 18073207
Int J Biochem Cell Biol. 2014 Apr;49:69-74
pubmed: 24440758
Nat Commun. 2014 Dec 15;5:5811
pubmed: 25503978
Life Sci Alliance. 2022 May 30;5(10):
pubmed: 35636967
Methods Enzymol. 1984;107:281-94
pubmed: 6503714
Circ Res. 2014 Mar 28;114(7):1162-73
pubmed: 24677236
Cell Cycle. 2005 Mar;4(3):352-5
pubmed: 15701970
Biochem Biophys Res Commun. 2004 Aug 13;321(1):234-40
pubmed: 15358240
FEBS J. 2009 Mar;276(5):1440-9
pubmed: 19187238
J Clin Invest. 2008 Mar;118(3):1123-31
pubmed: 18292814
Nat Rev Cancer. 2018 Jun;18(6):341-358
pubmed: 29674709
Nat Commun. 2021 Jul 1;12(1):4074
pubmed: 34210960
Trends Cell Biol. 2014 Jan;24(1):26-34
pubmed: 24295852
Nat Rev Cancer. 2012 Jan 24;12(2):89-103
pubmed: 22270953
Nature. 2010 Apr 1;464(7289):783-7
pubmed: 20208517
Methods Enzymol. 1985;117:400-14
pubmed: 4079811
J Cell Biol. 1992 Nov;119(3):629-41
pubmed: 1383237
Oncogene. 1989 Nov;4(11):1383-8
pubmed: 2554238
J Clin Invest. 2008 Mar;118(3):1110-22
pubmed: 18274674
Nature. 2019 Apr;568(7753):511-516
pubmed: 30971826
J Biol Chem. 2008 Jul 25;283(30):21267-77
pubmed: 18495663
Nat Chem Biol. 2010 Dec;6(12):900-6
pubmed: 21079601
Biochem Biophys Res Commun. 1995 Aug 24;213(3):746-51
pubmed: 7654233
Nature. 1995 Feb 23;373(6516):702-5
pubmed: 7854453
Oncogene. 2019 Mar;38(11):1936-1950
pubmed: 30390071
J Biol Chem. 1946 Aug;164(2):563-8
pubmed: 21001153
Cancer Sci. 2008 Jan;99(1):14-22
pubmed: 17953713
J Cell Biol. 1994 Apr;125(2):313-20
pubmed: 8163548
Front Immunol. 2021 Dec 03;12:775151
pubmed: 34925346
Mol Oncol. 2015 Nov;9(9):1760-72
pubmed: 26119717
Circulation. 2021 Aug 17;144(7):559-574
pubmed: 34162223
ACS Chem Biol. 2011 Mar 18;6(3):245-51
pubmed: 21121641
Antioxid Redox Signal. 2018 Jan 1;28(1):44-61
pubmed: 28816057
Antioxid Redox Signal. 2011 Aug 15;15(4):855-71
pubmed: 21395478
Biochem Biophys Res Commun. 1990 Dec 31;173(3):1179-85
pubmed: 2148475
Cancer Res. 2008 Jul 1;68(13):5363-9
pubmed: 18593938
Nat Rev Drug Discov. 2008 Jun;7(6):504-16
pubmed: 18511928
Cold Spring Harb Perspect Biol. 2013 Jul 01;5(7):
pubmed: 23818496
Sci Rep. 2016 Feb 16;6:21140
pubmed: 26879174
Mol Cell Biol. 1991 Dec;11(12):6084-92
pubmed: 1658624
FEBS J. 2010 Jun;277(11):2454-62
pubmed: 20477872
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
pubmed: 7984417